SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-014012
Filing Date
2020-06-26
Accepted
2020-06-26 17:03:25
Documents
7
Period of Report
2020-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20200625_8k.htm 8-K 34666
2 EXHIBIT 10.1 ex_191612.htm EX-10.1 266156
3 EXHIBIT 10.2 ex_191613.htm EX-10.2 173590
4 EXHIBIT 10.3 ex_191614.htm EX-10.3 107031
5 EXHIBIT 10.4 ex_191615.htm EX-10.4 168394
6 EXHIBIT 10.5 ex_191616.htm EX-10.5 74117
7 EXHIBIT 10.6 ex_191617.htm EX-10.6 60441
  Complete submission text file 0001437749-20-014012.txt   886015
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52091 | Film No.: 20994902
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services